Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 297 clinical trials
featured
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY

Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY

  • 1026 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

The objectives of this study are to evaluate the safety and efficacy of Zimura intravitreal administration in patients with geographic atrophy secondary to age-related macular degeneration (AMD

  • 0 views
  • 24 Jun, 2021
  • 1 location
Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration

neovascularization (CNV) associated with age-related macular degeneration (AMD).

fluorescein angiography
angiography
neovascularization
age-related macular degeneration
photodynamic therapy
  • 38 views
  • 07 Nov, 2020
  • 1 location
OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

A 2-year, phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.

  • 0 views
  • 05 Aug, 2021
  • 46 locations
OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

A 2-year phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.

  • 0 views
  • 01 Aug, 2021
  • 51 locations
Phase III Study Assessing the Efficacy Safety and Immunogenicity of SOK583A1 Versus Eylea in Patients With Neovascular Age-related Macular Degeneration

Purpose and rationale: To demonstrate similar efficacy, safety and immunogenicity of SOK583A1 and Eylea EU as per Eylea approved treatment regimen in patients with nAMD. The primary clinical question of interest is: Does SOK583A1 have similar efficacy as Eylea EU in terms of mean change in BCVA score in participants …

  • 0 views
  • 17 Jul, 2021
  • 38 locations
Copaxone in Age Related Macular Degeneration

The purpose of the project is to investigate in eyes with dry AMD, the efficacy and safety as preventive therapy of the immunomodulatory substance named copaxone which had been proven as

age-related macular degeneration
blindness
  • 43 views
  • 07 Nov, 2020
  • 1 location
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

patients with neovascular age related macular degeneration.

bevacizumab
verteporfin
age-related macular degeneration
photodynamic therapy
corrected visual acuity
  • 14 views
  • 07 Nov, 2020
  • 1 location
Subretinal Macugen for Neovascular Age-Related Macular Degeneration

The purpose of this study is to assess the efficacy of pegaptanib (Macugen®) for neovascular (exudative) age-related macular degeneration (AMD) when the first dose is administered to the

fluorescein angiography
angiography
pegaptanib
age-related macular degeneration
wet age-related macular degeneration
  • 20 views
  • 07 Nov, 2020
  • 1 location
Connection Between Periodontitis and Exudative Age-related Macular Degeneration

as periodontitis, increase aqueous flare and possibly activates exudative age-related macular degeneration.

anti-infective
  • 20 views
  • 26 Jan, 2021
  • 1 location